Zhejiang Sunflower Great Health (300111.SZ): Some products from Beide Pharmaceutical are expected to be selected for centralized procurement.

17:25 11/02/2026

Sunflower (300111.SZ) announced that its subsidiary Zhejiang Beide Pharmaceutical Co., Ltd. (hereinafter referred to as "Beide Pharmaceutical") recently participated in the declaration for the continuation of procurement of drugs in the 1st-8th batches (excluding insulin special procurement) under the national organization, according to the National Organization for the continuation of procurement of drugs in the expired varieties after the expiration of the agreement (hereinafter referred to as the "continuation procurement office") publicized the tentative selection results on February 10, 2026. The announcement shows that some products of Beide Pharmaceutical are tentatively selected for this centralized procurement. The selected products, clarithromycin tablets and simvastatin tablets, are both on the national medical insurance catalog.

Zhejiang Sunflower Great Health (300111.SZ) announced that its subsidiary Zhejiang Baiter Pharmaceutical Co., Ltd. (hereinafter referred to as "Baiter Pharmaceutical") recently participated in the declaration for the follow-up procurement of the first to eighth batches (excluding insulin special procurement, the same below) of the national organized centralized drug procurement agreement. According to the "Notice of the Proposed Selected Results for the Follow-up Procurement of the National Organized Centralized Drug Procurement Agreement at the End of the Agreement Period" released by the Follow-up Procurement Office of the National Organized Centralized Drug Procurement on February 10, 2026, some products of Baiter Pharmaceutical are proposed to be selected for this centralized procurement. The proposed selected products in this procurement include clarithromycin tablets and simvastatin tablets, both of which are included in the national medical insurance catalog.

On February 11, JIUMAOJIU (09922) spent HK$1.9623 million to repurchase 866,000 shares.

China Wuyi Co., Ltd. (000797.SZ) plans to form a consortium to collectively participate in the bidding for the Philippines' construction renovation and upgrade project.

On February 11, MNSO(09896) repurchased 17,400 shares for 658,900 Hong Kong dollars.

On February 11, JIUMAOJIU (09922) spent HK$1.9623 million to repurchase 866,000 shares.

China Wuyi Co., Ltd. (000797.SZ) plans to form a consortium to collectively participate in the bidding for the Philippines' construction renovation and upgrade project.

On February 11, MNSO(09896) repurchased 17,400 shares for 658,900 Hong Kong dollars.